Plasma osteopontin levels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system

@article{Vordermark2006PlasmaOL,
  title={Plasma osteopontin levels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system},
  author={Dirk Vordermark and Harun M. Said and Astrid Katzer and Thomas Kuhnt and Gabriele Haensgen and Juergen Dunst and Michael Flentje and Matthias Bache},
  journal={BMC Cancer},
  year={2006},
  volume={6},
  pages={207 - 207}
}
The tumor-associated glycoprotein osteopontin (OPN) is discussed as a plasma surrogate marker of tumor hypoxia and as an indicator of the presence of pleural mesothelioma in asbestos-exposed individuals. The clinical introduction of plasma OPN measurements requires the availability of a reliable enzyme-linked immunosorbence assay (ELISA). We compared previously described and currently available ELISA systems on 88 archival plasma samples obtained from patients with head and neck or cervix… CONTINUE READING
28 Citations
23 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 28 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 23 references

Similar Papers

Loading similar papers…